Thanks for the info kem60. I believe over the next few months TSRX will go through the roof. I used to trade this stock, but now I invest in this stock. Lots of catalysts to drive the price up -- more partnerships, ESTABLISH-2 results, additional indications, NDA filing, FDA approval, gyrase program, etc.
The last conference call was interesting with the changing of prescribing trends and resistance trends for MRSA. Combine that with Zyvox not going generic until mid-2016 and TSRX is setting up nicely.